(Q22252593)

30 July 2017

1 reference

title

Hallucinogens: An update (English)

0 references

Hallucinogens: an update (English)

1 reference

30 July 2017

John H. Halpern

1

0 references

John H Halpern

series ordinal

1

1 reference

PubMed ID

13678554

30 July 2017

language of work or name

English

0 references

publication date

September 2003

0 references

1 October 2003

1 reference

Current Psychiatry Reports

30 July 2017

2 references

30 July 2017

5

1 reference

30 July 2017

5

1 reference

30 July 2017

347-354

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-003-0067-4

30 July 2017

0 references

cites work

Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A.

1 reference

https://api.crossref.org/works/10.1007%2FS11920-003-0067-4

Drug use and sexual risk behavior among gay and bisexual men who attend circuit parties: a venue-based comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-003-0067-4

Visual Phenomenology of the LSD Flashback

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-003-0067-4

Subjective reports of the effects of MDMA in a clinical setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-003-0067-4

Ketamine psychedelic therapy (KPT): a review of the results of ten years of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-003-0067-4

A Clinical Plan for MDMA (Ecstasy) in the Treatment of Posttraumatic Stress Disorder (PTSD): Partnering with the FDA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-003-0067-4

Navajo Peyote Use: Its Apparent Safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-003-0067-4

LSD-assisted psychotherapy with terminal cancer patients

21 January 2018

1 reference

12 December 2020

Human research on MDMA (3,4-methylene- dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change

1 reference

12 December 2020

The 'sextasy' craze. Clubland's dangerous party mix: Viagra and ecstasy

1 reference

12 December 2020

Inhibitory effects of ibogaine on cocaine self-administration in rats

1 reference

12 December 2020

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users

1 reference

12 December 2020

ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE

2 references

12 December 2020

https://api.crossref.org/works/10.1007%2FS11920-003-0067-4

7 January 2021

inferred from DOI database lookup

MDMA ("Ecstasy") abuse and high-risk sexual behaviors among 169 gay and bisexual men

1 reference

12 December 2020

Hallucinogen persisting perception disorder: what do we know after 50 years?

1 reference

12 December 2020

Iboga compounds reverse the behavioural disinhibiting and corticosterone effects of acute methamphetamine: Implications for their antiaddictive properties

1 reference

12 December 2020

Clonidine treatment for hallucinogen persisting perception disorder

1 reference

12 December 2020

Addiction treatment strives for legitimacy

1 reference

12 December 2020

Hallucinogens on the Internet: a vast new source of underground drug information

1 reference

12 December 2020

LSD in the supportive care of the terminally ill cancer patient

1 reference

12 December 2020

Drug use and life style among college undergraduates: a 30-year longitudinal study

1 reference

12 December 2020

How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?

1 reference

12 December 2020

Effect of peyote on human chromosomes. Cytogenetic study of the Huichol Indians of Northern Mexico.

1 reference

12 December 2020

Peyote in the treatment of alcoholism among American Indians.

1 reference

12 December 2020

Effects of ibogaine on acute signs of morphine withdrawal in rats: independence from tremor

1 reference

12 December 2020

Psychiatric disorders in Ecstasy (MDMA) users: a literature review focusing on personal predisposition and drug history

1 reference

12 December 2020

A review of 19 double-blind placebo-controlled studies in social anxiety disorder (social phobia).

1 reference

12 December 2020

Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist

1 reference

12 December 2020

Attenuation of anticipation: A therapeutic use of lysergic acid diethylamide

1 reference

12 December 2020

LSD-assisted psychotherapy in patients with terminal cancer.

1 reference

12 December 2020

18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action.

1 reference

12 December 2020

Altered states: the clinical effects of Ecstasy.

1 reference

12 December 2020

Salvia divinorum and salvinorin A: new pharmacologic findings

1 reference

12 December 2020

Low-dose MDMA ("ecstasy") induces vasopressin secretion.

1 reference

12 December 2020

Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up

1 reference

12 December 2020

Hallucinogen-induced relief of obsessions and compulsions

1 reference

12 December 2020

10.1007/S11920-003-0067-4

Identifiers

DOI

1 reference

PubMed ID

13678554

Dimensions Publication ID

30 July 2017

0 references

1 reference

PubMed ID

13678554